Home › NCT05476523

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Who can join

Ages 18 to 90 · All sexes

Inclusion Criteria:

* Men and women ages between 18 and 90 years old
* Normal or corrected vision
* Ability to follow instructions
* Willing and able to sign an informed consent form

Exclusion Criteria:

* Inability to sit for 20 minutes on a chair in a calm manner
* Personal or 1st degree relative history of epilepsy
* Additional neurological diseases
* Drug or alcohol abuse

About the study

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

What is being tested

• NeuraLight (other)

Sponsor: NeuraLight · Participants: 2,000 · Started: Jul 22, 2022

Contact the study team

• Eitan Raveh, PhD · Phone: +972-58-6277947

Official record on ClinicalTrials.gov — NCT05476523

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.